The lipid panel (total, LDL, and HDL cholesterol, as well as triglycerides) —in addition to apolipoproteins (ApoA1 and ApoB), Lp(a), hsCRP, homocysteine, and Lp-pla2— are used to manage and monitor CHD. The gene discussed is APOA1; the disease is coronary artery disorder.